Skip to main content
Day 1: Monday, June 30
Assessing the Current State of Prenatal Supplement Use
Day 2: Tuesday, July 1
Evaluating Evidence and Setting Research Directions
9:30 AM — 9:45 AM
Welcome and Opening Remarks

Workshop goals, objectives, and structure.

Andrew A. Bremer, M.D., Ph.D., M.A.S. picture
Andrew A. Bremer, M.D., Ph.D., M.A.S.
Jaime Gahche, Ph.D., M.P.H. picture
Jaime Gahche, Ph.D., M.P.H.
9:45 AM — 10:05 AM
Keynote Presentation

Overview of the current state of prenatal supplement use and its critical importance.

Nicole Marshall, M.D., M.C.R., IBCLC, FACOG, FABM picture
Nicole Marshall, M.D., M.C.R., IBCLC, FACOG, FABM
10:05 AM — 12:00 PM
Session 1: Nutrient Contributions to Intakes from Prenatals and Prenatal Supplement Products

Discuss prenatal supplements' contributions to total nutrient intakes for pregnant women (NHANES, other large cohorts, and surveys) and review of types of prenatal dietary supplements available in the U.S. market and their nutrient content.

Regan Bailey, Ph.D. picture
Regan Bailey, Ph.D.
Alexandra E. Cowan-Pyle, Ph.D. picture
Alexandra E. Cowan-Pyle, Ph.D.
Katherine Sauder, Ph.D. picture
Katherine Sauder, Ph.D.
Edwina Wambogo, Ph.D., M.P.H., R.D. picture
Edwina Wambogo, Ph.D., M.P.H., R.D.
Laura M. Borgelt, Pharm.D., MBA, FCCP, BCPS picture
Laura M. Borgelt, Pharm.D., MBA, FCCP, BCPS
12:00 PM — 12:30 PM
Panel: Session 1 Discussion
Regan Bailey, Ph.D. picture
Regan Bailey, Ph.D.
Alexandra E. Cowan-Pyle, Ph.D. picture
Alexandra E. Cowan-Pyle, Ph.D.
Katherine Sauder, Ph.D. picture
Katherine Sauder, Ph.D.
Edwina Wambogo, Ph.D., M.P.H., R.D. picture
Edwina Wambogo, Ph.D., M.P.H., R.D.
Laura M. Borgelt, Pharm.D., MBA, FCCP, BCPS picture
Laura M. Borgelt, Pharm.D., MBA, FCCP, BCPS
12:30 PM — 1:30 PM
Lunch (on your own)
1:30 PM — 2:15 PM
Session 2: Nutrient Requirements During Pregnancy, including Special Population Groups

Micronutrient requirements during pregnancy and current evidence for optimal outcomes. 

E
Emily R. Smith, ScD, MPH
2:15 PM — 3:00 PM
Panel: Challenges in Formulating Prenatals

Discuss formulation considerations for prenatal supplements (over-supplementation, contaminants, interactions).

Andrea Wong, Ph.D. picture
Andrea Wong, Ph.D.
Susan H. Mitmesser, Ph.D. picture
Susan H. Mitmesser, Ph.D.
3:00 PM — 3:15 PM
Break
3:15 PM — 3:45 PM
Panel Discussion

Key insights and Q&A with Day 1 presenters.

Regan Bailey, Ph.D. picture
Regan Bailey, Ph.D.
Alexandra E. Cowan-Pyle, Ph.D. picture
Alexandra E. Cowan-Pyle, Ph.D.
Katherine Sauder, Ph.D. picture
Katherine Sauder, Ph.D.
Edwina Wambogo, Ph.D., M.P.H., R.D. picture
Edwina Wambogo, Ph.D., M.P.H., R.D.
Laura M. Borgelt, Pharm.D., MBA, FCCP, BCPS picture
Laura M. Borgelt, Pharm.D., MBA, FCCP, BCPS
E
Emily R. Smith, ScD, MPH
Andrea Wong, Ph.D. picture
Andrea Wong, Ph.D.
Susan H. Mitmesser, Ph.D. picture
Susan H. Mitmesser, Ph.D.
4:00 PM
Adjourn
9:30 AM — 9:45 AM
Welcome and Introduction to Day 2
Jaime Gahche, Ph.D., M.P.H. picture
Jaime Gahche, Ph.D., M.P.H.
Session 4: Micronutrient Focus

Identify critical micronutrients and evaluate optimal ranges in prenatal supplements.

James L. Mills, M.D., M.S. picture
James L. Mills, M.D., M.S.
Julia Finkelstein, Sc.D., M.P.H. picture
Julia Finkelstein, Sc.D., M.P.H.
9:45 AM — 10:45 AM
Session 4a: One-Carbon Metabolism Micronutrients

Folate, B12, and choline: Evidence on roles and optimal levels.

 

K
Krista Crider, Ph.D.
Y
Yvonne Lamers, Ph.D.
Steven Zeisel, Ph.D. picture
Steven Zeisel, Ph.D.
10:45 AM — 11:00 AM
Break
11:00 AM — 12:00 PM
Session 4b: Minerals (and Vitamin D)

Iron, iodine, calcium, and magnesium: Evidence review and gaps.

Kimberly O’Brien, Ph.D. picture
Kimberly O’Brien, Ph.D.
Elizabeth N. Pearce, M.D., M.Sc. picture
Elizabeth N. Pearce, M.D., M.Sc.
Michael K. Georgieff, M.D. picture
Michael K. Georgieff, M.D.
12:00 PM — 12:30 PM
Panel: Session 4a and 4b Discussion
Y
Yvonne Lamers, Ph.D.
Steven Zeisel, Ph.D. picture
Steven Zeisel, Ph.D.
Kimberly O’Brien, Ph.D. picture
Kimberly O’Brien, Ph.D.
Elizabeth N. Pearce, M.D., M.Sc. picture
Elizabeth N. Pearce, M.D., M.Sc.
Michael K. Georgieff, M.D. picture
Michael K. Georgieff, M.D.
12:30 PM — 1:30 PM
Lunch (on your own)
1:30 PM — 1:50 PM
Session 4c: Omega-3 Fatty Acids

Explore the evidence for Omega-3 fatty acids in supporting maternal and fetal health and consider optimal Omega-3 levels in prenatal products.

E
Emily Oken, M.D.
1:50 PM — 2:10 PM
Session 4d: Lutein/Zeaxanthin
Elizabeth J. Johnson, Ph.D., FASN, FACN, FICS picture
Elizabeth J. Johnson, Ph.D., FASN, FACN, FICS
2:10 PM — 2:30 PM
Panel: Session 4c & 4d Discussion
E
Emily Oken, M.D.
Elizabeth J. Johnson, Ph.D., FASN, FACN, FICS picture
Elizabeth J. Johnson, Ph.D., FASN, FACN, FICS
2:30 PM — 2:45 PM
Break
2:45 PM — 3:15 PM
Session 5: Research Needs and Data Gaps

Identify priority areas for research, including data collection on use patterns, biomarkers, and outcomes.

Patrick J. Stover, Ph.D. picture
Patrick J. Stover, Ph.D.
3:15 PM — 4:15 PM
Breakout Groups: Research Recommendations

Small group discussions to draft recommendations for further research and data collection.

4:15 PM — 4:30 PM
Closing Remarks

Final summary, outcomes, and next steps.

Jaime Gahche, Ph.D., M.P.H. picture
Jaime Gahche, Ph.D., M.P.H.
4:30 PM
Adjourn

Detected timezone